Given the effects on cell cycle arrest, there is potential for CDK4/6 inhibitors and radiotherapy (RT) to work synergistically, enhancing the effect of RT due to cancer cells’ arrest in a more radiosensitive phase [9]. Here, CDK4 is linked to cancer.